jrnl2569

Publication Venue For

  • Synchronous and metachronous bilateral breast cancer: clinicopathologic characteristics and prognostic outcomes.  92:1-9. 2019
  • PD-L1 expression in non–small cell lung cancer: evaluation of the diagnostic accuracy of a laboratory-developed test using clone E1L3N in comparison with 22C3 and SP263 assays.  90:54-59. 2019
  • PTEN and ERG detection in multiparametric magnetic resonance imaging/ultrasound fusion targeted prostate biopsy compared to systematic biopsy.  90:20-26. 2019
  • Tumor immune microenvironment in non–muscle-invasive urothelial carcinoma of the bladder.  89:24-32. 2019
  • Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations.  85:1-9. 2019
  • Histologic findings associated with false-positive multiparametric magnetic resonance imaging performed for prostate cancer detection.  83:159-165. 2019
  • SWI/SNF protein expression status in fumarate hydratase–deficient renal cell carcinoma: immunohistochemical analysis of 32 tumors from 28 patients.  77:139-146. 2018
  • Defining the optimal method for reporting prostate cancer grade and tumor extent on magnetic resonance/ultrasound fusion–targeted biopsies.  76:68-75. 2018
  • Pathologic and clinical characteristics of early onset renal cell carcinoma.  74:25-31. 2018
  • Prognostic outcomes in advanced breast cancer: the metastasis-free interval is important.  70:70-76. 2017
  • Clinical and pathological factors related to brain relapse-free survival in breast cancer patients—reply.  69:142. 2017
  • Corrigendum to “Diagnostic utility of IDH1/2 mutations to distinguish dedifferentiated chondrosarcoma from undifferentiated pleomorphic sarcoma of bone” (Human Pathology (2017) 65 (239–246) (S0046817717301727) (10.1016/j.humpath.2017.05.015)).  69:143. 2017
  • The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer.  69:110-117. 2017
  • MicroRNAs, promising biomarkers in the diagnosis of Xp11 translocation RCC—reply.  68:206-207. 2017
  • MicroRNA expression profiling of Xp11 renal cell carcinoma.  67:18-29. 2017
  • Perineural invasion by prostate cancer on MR/US fusion targeted biopsy is associated with extraprostatic extension and early biochemical recurrence after radical prostatectomy.  66:206-211. 2017
  • Diagnostic utility of IDH1/2 mutations to distinguish dedifferentiated chondrosarcoma from undifferentiated pleomorphic sarcoma of bone.  65:239-246. 2017
  • Clinicopathological factors associated with survival in patients with breast cancer brain metastasis.  64:53-60. 2017
  • GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator.  64:83-90. 2017
  • Immune-checkpoint status in penile squamous cell carcinoma: a North American cohort.  59:55-61. 2017
  • High-resolution telomere fluorescence in situ hybridization reveals intriguing anomalies in germ cell tumors.  54:106-112. 2016
  • The utility of STAT6 and ALDH1 expression in the differential diagnosis of solitary fibrous tumor versus prostate-specific stromal neoplasms.  54:184-188. 2016
  • Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladder.  53:8-13. 2016
  • Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder.  47:20-25. 2016
  • Renal carcinoma associated with a novel succinate dehydrogenase A mutation: A case report and review of literature of a rare subtype of renal carcinoma.  46:1951-1955. 2015
  • Characterization of estrogen receptor-negative/progesterone receptor-positive breast cancer.  46:1776-1784. 2015
  • Sinonasal renal cell-like adenocarcinomas: Robust carbonic anhydrase expression.  46:1598-1606. 2015
  • Smooth muscle and adenoma-like renal tumor: A previously unreported variant of mixed epithelial stromal tumor or a distinctive renal neoplasm?.  46:894-905. 2015
  • Immunohistochemical expression of ARID1A in penile squamous cell carcinomas: A tissue microarray study of 112 cases.  46:761-766. 2015
  • Human papillomavirus infection and immunohistochemical p16INK4a expression as predictors of outcome in penile squamous cell carcinomas.  46:532-540. 2015
  • Utility of uroplakin II expression as a marker of urothelial carcinoma.  46:58-64. 2015
  • ARID1A immunohistochemistry improves outcome prediction in invasive urothelial carcinoma of urinary bladder 2014
  • African Americans with oropharyngeal carcinoma have significantly poorer outcomes despite similar rates of human papillomavirus-mediated carcinogenesis.  45:310-319. 2014
  • Comprehensive profile of GATA binding protein 3 immunohistochemical expression in primary and metastatic renal neoplasms.  45:244-248. 2014
  • Changing prognostic factors in osteosarcoma: Analysis of 381 cases from two institutions.  45:1688-1696. 2014
  • Clear cell papillary renal cell carcinoma: Micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.  45:1130-1138. 2014
  • GATA3 expression in small cell carcinoma of bladder and prostate and its potential role in determining primary tumor origin.  45:1682-1687. 2014
  • Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinoma.  44:2668-2676. 2013
  • Immunohistochemical profile of the penile urethra and differential expression of GATA3 in urothelial versus squamous cell carcinomas of the penile urethra.  44:2760-2767. 2013
  • The epidermal growth factor receptor is frequently overexpressed in penile squamous cell carcinomas: A tissue microarray and digital image analysis study of 112 cases.  44:2690-2695. 2013
  • The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas.  44:2651-2657. 2013
  • Dysregulation of the mammalian target of rapamycin pathway in chromophobe renal cell carcinomas.  44:2323-2330. 2013
  • Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma.  44:2071-2074. 2013
  • Relevance of the mammalian target of rapamycin pathway in the prognosis of patients with high-risk non-muscle invasive bladder cancer.  44:1766-1772. 2013
  • Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors.  44:1293-1299. 2013
  • Dysregulation of mammalian target of rapamycin pathway in plasmacytoid variant of urothelial carcinoma of the urinary bladder.  44:612-622. 2013
  • Expression of the vitamin D-activating enzyme 1α-hydroxylase (CYP27B1) decreases during melanoma progression.  44:374-387. 2013
  • Immunoexpression status and prognostic value of mammalian target of rapamycin and hypoxia-induced pathway members in papillary cell renal cell carcinomas.  43:2129-2137. 2012
  • GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumor.  43:2033-2040. 2012
  • Immunohistochemical expression of minichromosome maintenance complex protein 2 predicts biochemical recurrence in prostate cancer: A tissue microarray and digital imaging analysis-based study of 428 cases.  43:1852-1865. 2012
  • High epidermal growth factor receptor immunohistochemical expression in urothelial carcinoma of the bladder is not associated with EGFR mutations in exons 19 and 21: A study using formalin-fixed, paraffin-embedded archival tissues.  43:1590-1595. 2012
  • Distribution and characterization of subtypes of penile intraepithelial neoplasia and their association with invasive carcinomas: A pathological study of 139 lesions in 121 patients.  43:1020-1027. 2012
  • Factors associated with residual disease after initial breast-conserving surgery for ductal carcinoma in situ.  43:986-993. 2012
  • Thyroid transcription factor 1 expression in a case of renal collecting duct carcinoma - Reply.  43:1154. 2012
  • A novel t(6;13)(q15;q34) translocation in a giant cell reparative granuloma (solid aneurysmal bone cyst).  43:952-957. 2012
  • Characteristics of positive surgical margins in robotic-assisted radical prostatectomy, open retropubic radical prostatectomy, and laparoscopic radical prostatectomy: A comparative histopathologic study from a single academic center.  43:254-260. 2012
  • Complex analysis of a recurrent pleomorphic hyalinizing angiectatic tumor of soft parts.  43:121-126. 2012
  • High-grade papillary urothelial carcinoma of the urinary tract: A clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center.  43:115-120. 2012
  • Hepatocyte nuclear factor-1β expression in clear cell adenocarcinomas of the bladder and urethra: Diagnostic utility and implications for histogenesis.  42:1613-1619. 2011
  • EGFR and KRAS mutations in metastatic lung adenocarcinomas..  42:1447-1453. 2011
  • Papillary urothelial neoplasm of low malignant potential of the urinary bladder: clinicopathologic and outcome analysis from a single academic center 2011
  • Adrenal lymphangioma: Clinicopathologic and immunohistochemical characteristics of a rare lesion.  42:1013-1018. 2011
  • Expression of vitamin D receptor decreases during progression of pigmented skin lesions.  42:618-631. 2011
  • Toluene optic neurotoxicity: Magnetic resonance imaging and pathologic features.  42:295-298. 2011
  • Pathology graduate medical education (overview from 2006-2010).  42:763-769. 2011
  • Merkel cell carcinoma: Correlation of KIT expression with survival and evaluation of KIT gene mutational status.  41:1405-1412. 2010
  • Oncogenic BRAF-positive dysplastic nevi and the tumor suppressor IGFBP7-challenging the concept of dysplastic nevi as precursor lesions?.  41:886-894. 2010
  • Specific detection of prostate cancer cells in urine by multiplex immunofluorescence cytology.  40:924-933. 2009
  • Juvenile juxtacortical chondromyxoid fibroma of bone: a case report.  39:960-965. 2008
  • Prostatic adenocarcinoma in colorectal biopsy: clinical and pathologic features.  39:543-549. 2008
  • Colorectal adenocarcinoma involving the prostate: report of 9 cases.  38:1836-1841. 2007
  • Pathology graduate medical education (overview from 1926 to 2005).  37:923-928. 2006
  • Current challenges and opportunities for research on borderline ovarian tumors.  35:961-970. 2004
  • Recommendations for the reporting of bone tumors.  35:1173-1178. 2004
  • Expression of CEA, Tag-72, and Lewis-Y Antigen in Primary and Metastatic Lesions of Ovarian Carcinoma.  34:1016-1021. 2003
  • Osteosarcoma in a patient with McCune-Albright syndrome and Mazabraud's syndrome: A case report emphasizing the cytological and cytogenetic findings.  34:1354-1357. 2003
  • Surgical Pathology of Pulmonary Thromboendarterectomy: A Study of 54 Cases from 1990 to 2001.  34:1290-1298. 2003
  • Threshold for Diagnosing Prostate Cancer over Time.  34:1116-1118. 2003
  • Competency-based residency training in pathology: Challenges and opportunities.  33:3-6. 2002
  • Altered global methylation of DNA: An epigenetic difference in susceptibility for lung cancer is associated with its progression.  32:856-862. 2001
  • Trends in pathology graduate medical education.  32:671-676. 2001
  • A prospective trial of telepathology for intraoperative consultation (frozen sections).  31:781-785. 2000
  • The expression of Ep-CAM (17-1A) in squamous cell cancers of the lung.  31:482-487. 2000
  • The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung.  31:1068-1073. 2000
  • Demonstrability of the glycoprotein A-80 in postradiation prostatic carcinoma.  30:1474-1478. 1999
  • Expression of proopiomelanocortin (POMC)-derived melanocyte-stimulating hormone (MSH) and adrenocorticotropic hormone (ACTH) peptides in skin of basal cell carcinoma patients.  30:208-215. 1999
  • Expression of nm23-H1 in prostatic intraepithelial neoplasia and adenocarcinoma.  27:1021-1024. 1996
  • Adenovirus myocarditis: Retrospective diagnosis by gene amplification from formalin-fixed, paraffin-embedded tissues.  25:831-834. 1994
  • Growth factors in monoclonal light-chain-related renal diseases.  25:883-892. 1994
  • Induction of proliferating cell nuclear antigen in differentiated keratinocytes of human papillomavirus-infected lesions.  25:343-348. 1994
  • Reply.  25:1375-1376. 1994
  • Atypical cytomegalovirus inclusions in gastrointestinal biopsy specimens from patients with the acquired immunodeficiency syndrome: Diagnostic role of in situ nucleic acid hybridization.  23:1019-1026. 1992
  • Human papillomavirus type 16 and 18 gene expression in cervical neoplasias.  23:117-128. 1992
  • Intestinal microsporidiosis as a cause of diarrhea in HIV-infected patients: A report of 20 cases.  21:475-81. 1990
  • Intestinal microsporidiosis as a cause of diarrhea in human immunodeficiency virus-infected patients: A report of 20 cases.  21:475-481. 1990
  • The diagnosis of Wegener's granulomatosis from transbronchial biopsy specimens.  21:838-842. 1990
  • Uterine herpes virus infection with multifocal necrotizing endometritis.  20:1021-1024. 1989
  • Amiodarone lung: Pathologic finding in clinically toxic patients.  18:349-354. 1987
  • Stromal proliferations of the breast: An ultrastructural and immunohistochemical evaluation of cystosarcoma phyllodes, juvenile fibroadenoma, and fibroadenoma.  18:45-49. 1987
  • Black thyroid: Clinical manifestations, ultrastructural findings, and possible mechanisms.  16:72-78. 1985
  • Small cell carcinoma of the esophagus: Evidence for a unified histogenesis.  15:460-468. 1984
  • Why physicians don't pursue abnormal laboratory tests: An investigation of hypercalcemia and the follow-up of abnormal test results.  15:75-78. 1984